General form of registration statement for all companies including face-amount certificate companies

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)

v3.21.4
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)
 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
OPERATING REVENUE:              
TOTAL OPERATING REVENUE $ 156,520,255 $ 128,840,991 $ 459,503,232 $ 360,664,280 $ 485,541,291 $ 145,894,832 $ 87,696,695
OPERATING EXPENSES (INCOME):              
Medical Expenses 161,662,423 127,015,976 459,233,085 348,258,272 485,513,143 141,442,457 92,481,777
Premium Deficiency Reserve 1,600,000 1,072,540 4,600,000 (1,304,962) (20,539,364) 6,363,652 14,175,712
Corporate, General and Administrative Expenses 20,433,538 13,742,904 53,883,267 36,773,545 53,390,338 36,423,532 28,541,520
Sales and Marketing Expenses 491,418 278,663 1,118,160 631,073 1,502,634 801,685 1,870,004
Depreciation 456,418 245,488 1,218,796 613,329 795,172 399,177 342,196
TOTAL OPERATING EXPENSES 184,643,797 142,355,570 520,053,309 384,971,257 520,661,923 185,430,503 137,411,208
OPERATING LOSS (28,123,542) (13,514,579) (60,550,077) (24,306,977) (35,120,632) (39,535,671) (49,714,513)
OTHER INCOME (EXPENSES):              
Interest Expense, Net (4,643,254) (2,316,579) (13,130,628) (6,877,619) (9,970,260) (3,479,139) 44,235
Mark-to-Market Adjustment for Class D Warrants (1,401,686)   (12,063,265)        
Other         (290,684) 97,955 (103,734)
TOTAL OTHER INCOME (EXPENSE) (6,044,940) (2,316,579) (25,193,893) (6,877,619) (10,260,944) (3,381,184) (59,500)
NET LOSS (34,168,482) (15,831,158) (85,743,970) (31,184,596) (45,381,576) (42,916,855) (49,774,013)
NET LOSS ATTRIBUTABLE TO NON-CONTROLLING INTERESTS (2,801,965) 875,560 (8,043,678) (3,450,460) (4,307,071) (7,907,592) (5,972,718)
NET LOSS ATTRIBUTABLE TO CONTROLLING INTERESTS $ (31,366,517) $ (16,706,718) $ (77,700,292) $ (27,734,136) $ (41,074,505) $ (35,009,263) $ (43,801,295)
NET LOSS PER SHARE (BASIC) $ (0.45) $ (0.25) $ (1.14) $ (0.42) $ (0.62) $ (0.74) $ (1.78)
NET LOSS PER SHARE (DILUTED) $ (0.45) $ (0.25) $ (1.14) $ (0.42) $ (0.62) $ (0.74) $ (1.78)
Capitated Revenue              
OPERATING REVENUE:              
TOTAL OPERATING REVENUE $ 152,276,992 $ 124,461,275 $ 447,137,121 $ 351,018,290 $ 471,551,241 $ 138,727,943 $ 86,465,658
Subtotal Other Patient Service Revenue              
OPERATING REVENUE:              
TOTAL OPERATING REVENUE $ 4,243,263 $ 4,379,716 $ 12,366,111 $ 9,645,990 $ 13,990,050 $ 7,166,889 $ 1,231,037